Google+

June 3-6, 2019 | Philadelphia, PA

Buzz Of Bio 

Double Helix Sponsor

loading...

Schedule at a glance

Registration Rates

Join the Mailing List

Buzz of BIO
Print Schedule

Congratulations to the Buzz of BIO Winners!    

Technologies of Tomorrow  

 

Pipelines of Promise 

 
averytherapeutics biomarck

Avery’s novel engineered tissue platform enhances cell therapy delivery by targeting the root cause of degenerative disease. Avery’s MyCardia™ treatment for heart failure demonstrated pre-clinical functional improvements anticipated to translate to a significant improvement in quality of life.

biomarck Pharmaceuticals is developing its lead compound, BIO-11006 for non-small cell lung cancer (NSCLC) and acute respiratory distress syndrome (ARDS). They have active IND’s for both indications and are conducting Phase 2 clinical studies in patients with NCSLC and ARDS in 2017/2018.

What will the winners receive?

Buzz of BIO winners receive one complimentary Convention Access & Partnering registration pass and the opportunity to give a Company Presentation in the BIO Business Forum in front of industry leaders. View the Buzz of BIO Contest Rules here. For questions, please contact Emily Longvall at elongvall@bio.org

 

Special thanks to our BIO Contest sponsor:

Amgen 2018

 
Thank you to our 2018 Sponsors

Double Helix Sponsors

Helix Sponsors

Premier Sponsors